Jo Varshney, PhD, DVM, discusses how VeriSIM Life’s innovative approach leverages artificial intelligence and multispecies data.
Jo Varshney, PhD, DVM
Advertisement
Jo Varshney, PhD, DVM, CEO and founder of VeriSIM Life.
Articles by Jo Varshney, PhD, DVM
Jo Varshney, PhD, DVM, discusses how artificial intelligence–powered simulations speed drug approvals and reduce clinical trial risk.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
CMS Proposes Nearly Flat 2027 Medicare Advantage Payment Rates
2
ICE Presence in Minnesota Health Care Settings Threatens Access to Essential Medical Care
3
AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule
4
Experts Warn CDC Childhood Immunization Schedule Revisions Could Reduce Uptake, Erode Public Trust
5
